Ginkgo Bioworks Holdings, Inc. (DNA)

NYSE: DNA · Real-Time Price · USD

12.37

+1.08 (9.57%)

At close: Nov 9, 2026, 4:00 PM EST

12.42

+0.05 (0.40%)

Pre-market: Nov 10, 2026, 7:01 AM EST

Ginkgo Bioworks Holdings Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	84.5	167.2	561.57	944.07	1,316	1,550
Short-Term Investments	200.86	255.42	-	-	-	-
Cash & Short-Term Investments	285.36	422.62	561.57	944.07	1,316	1,550
Cash Growth	-38.21%	-24.74%	-40.52%	-28.25%	-15.11%	307.04%
Accounts Receivable	11.49	24.26	22.44	17.9	82.47	136.14
Other Receivables	-	-	-	-	1.56	-
Receivables	11.49	24.26	22.44	30.19	84.03	147.7
Inventory	-	-	-	-	4.36	3.51
Prepaid Expenses	14	17.93	12.89	22.7	35.11	18.94
Restricted Cash	-	7.03	5.84	4.79	8.22	-
Other Current Assets	-	-	-	-	2.57	2.9
Total Current Assets	310.84	471.84	602.74	1,002	1,450	1,723
Property, Plant & Equipment	493.84	528.7	598.16	394.99	718.79	145.77
Long-Term Investments	14.56	15.07	48.7	78.57	113.73	115.23
Goodwill	-	-	-	49.24	60.21	21.31
Other Intangible Assets	39.73	56.92	72.51	82.74	111.04	21.64
Other Long-Term Assets	85.48	40.04	41.17	44.45	47.81	43.99
Total Assets	944.45	1,120	1,377	1,665	2,539	2,071

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	7.18	10.57	14.17	9.32	10.45	8.19
Accrued Expenses	52.28	15.57	19.19	49.87	52.3	85.14
Current Portion of Leases	-	22.81	28.97	17.47	29.33	0.75
Current Unearned Revenue	6.39	35.9	30.6	48.5	47.82	33.24
Other Current Liabilities	-	11.13	14.34	38.7	33.06	7.45
Total Current Liabilities	65.85	95.97	107.27	163.86	172.96	134.76
Long-Term Leases	397.2	417.08	438.77	221.84	413.26	22.28
Long-Term Unearned Revenue	71.98	75.18	98.78	158.06	174.77	155.99
Other Long-Term Liabilities	16.79	22.88	16.58	24.43	42.06	190.58
Total Liabilities	551.82	611.11	661.39	568.19	803.04	503.61

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	0.01	0.01	0.01	0.01	0.19	0.16
Additional Paid-In Capital	6,713	6,657	6,555	6,386	6,136	3,805
Retained Earnings	-6,321	-6,150	-5,838	-5,291	-4,398	-2,298
Comprehensive Income & Other	0.12	1.85	-1.81	1.48	-2.63	-1.72
Total Common Equity	392.64	508.59	716.06	1,097	1,736	1,505
Minority Interest	-	-	-	-	-	62.01
Shareholders' Equity	392.64	508.59	716.06	1,097	1,736	1,567
Total Liabilities & Equity	944.45	1,120	1,377	1,665	2,539	2,071

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	397.2	439.89	467.73	239.31	442.59	23.03
Net Cash (Debt)	-111.84	-17.27	93.84	704.76	873.2	1,527
Net Cash Growth	-	-	-86.69%	-19.29%	-42.81%	319.73%
Net Cash Per Share	-1.84	-0.31	1.81	14.50	20.79	44.90
Filing Date Shares Outstanding	63.97	58.21	54.37	50.03	51.81	43.99
Total Common Shares Outstanding	63.97	58.21	54.37	50.03	47.3	40.28
Working Capital	244.99	375.87	495.48	837.89	1,277	1,588
Book Value Per Share	6.14	8.74	13.17	21.93	36.71	37.37
Tangible Book Value	352.91	451.67	643.55	965.17	1,565	1,462
Tangible Book Value Per Share	5.52	7.76	11.84	19.29	33.09	36.30
Land	-	6.06	6.06	6.06	6.06	-
Buildings	-	49.76	48.26	47.03	-	-
Machinery	-	161.86	172.33	168.42	206.72	128.75
Construction In Progress	-	0.19	1.98	15.83	23.43	10.28
Leasehold Improvements	-	140.51	135.96	71.56	125.31	55.03

SEC Filings: 10-K · 10-Q